150 related articles for article (PubMed ID: 37879431)
1. Single antiplatelet therapy after left atrial appendage closure in patients with AF: safety and effectiveness.
Llagostera-Martín M; Cainzos M; Salvatella N; Cubero-Gallego H; Mas-Stachurska A; Sánchez-Carpintero A; Tizón-Marcos H; Calvo-Fernández A; Molina L; Vaquerizo B
Rev Esp Cardiol (Engl Ed); 2024 Feb; 77(2):150-157. PubMed ID: 37879431
[TBL] [Abstract][Full Text] [Related]
2. Long-term Event Reduction After Left Atrial Appendage Closure. Results of the Iberian Registry II.
López-Mínguez JR; Nogales-Asensio JM; Infante De Oliveira E; De Gama Ribeiro V; Ruiz-Salmerón R; Arzamendi-Aizpurua D; Costa M; Gutiérrez-García H; Fernández-Díaz JA; Martín-Yuste V; Rama-Merchán JC; Moreno-Gómez R; Benedicto-Buendía A; Íñiguez-Romo A
Rev Esp Cardiol (Engl Ed); 2019 Jun; 72(6):449-455. PubMed ID: 29754808
[TBL] [Abstract][Full Text] [Related]
3. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure.
Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ
Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344
[TBL] [Abstract][Full Text] [Related]
5. Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation.
Fayos-Vidal F; Arzamendi-Aizpurua D; Millán-Álvarez X; Guisado-Alonso D; Camps-Renom P; Prats-Sánchez L; Martínez-Domeño A; Delgado-Mederos R; Martí-Fàbregas J
Neurologia (Engl Ed); 2020; 35(1):10-15. PubMed ID: 28865942
[TBL] [Abstract][Full Text] [Related]
6. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes.
Jalal Z; Dinet ML; Combes N; Pillois X; Renou P; Sibon I; Iriart X; Thambo JB
Arch Cardiovasc Dis; 2017 Apr; 110(4):242-249. PubMed ID: 28065447
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous left atrial appendage closure in patients with primary hemostasis disorders and atrial fibrillation.
Dognin N; Salaun E; Champagne C; Domain G; O'Hara G; Philippon F; Paradis JM; Faroux L; Beaudoin J; O'Connor K; Bernier M; Rodés-Cabau J; Champagne J
J Interv Card Electrophysiol; 2022 Aug; 64(2):497-509. PubMed ID: 34822043
[TBL] [Abstract][Full Text] [Related]
9. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices.
Weise FK; Bordignon S; Perrotta L; Konstantinou A; Bologna F; Nagase T; Chen S; Chun KRJ; Schmidt B
EuroIntervention; 2018 Apr; 13(18):e2138-e2146. PubMed ID: 29400653
[TBL] [Abstract][Full Text] [Related]
10. Characteristics and outcome of patients with left atrial appendage closure in China: a single-center experience.
Zhang J; Li C; Zhou L; Sang C; Li S; Ma C
BMC Cardiovasc Disord; 2024 Feb; 24(1):108. PubMed ID: 38355458
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy is safe and efficient after left atrial appendage closure.
Maksym J; Mazurek T; Kochman J; Grygier M; Kapłon-Cieślicka A; Marchel M; Lodziński P; Piątkowski R; Wilimski R; Czub P; Fojt A; Karolczak N; Hendzel P; Opolski G
Kardiol Pol; 2018; 76(2):459-463. PubMed ID: 29350390
[TBL] [Abstract][Full Text] [Related]
12. 5-Year Outcomes After Left Atrial Appendage Closure: From the PREVAIL and PROTECT AF Trials.
Reddy VY; Doshi SK; Kar S; Gibson DN; Price MJ; Huber K; Horton RP; Buchbinder M; Neuzil P; Gordon NT; Holmes DR;
J Am Coll Cardiol; 2017 Dec; 70(24):2964-2975. PubMed ID: 29103847
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the presence of chronic kidney disease on percutaneous left trial appendage closure for atrial fibrillation: A single center experience.
Benini Tapias J; Flores-Umanzor E; Cepas-Guillén PL; Regueiro A; Sanchís L; Broseta JJ; Cases A; Freixa X
Nefrologia (Engl Ed); 2022; 42(3):290-300. PubMed ID: 36210618
[TBL] [Abstract][Full Text] [Related]
14. 4-Year Outcomes After Left Atrial Appendage Closure Versus Nonwarfarin Oral Anticoagulation for Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2022 Jan; 79(1):1-14. PubMed ID: 34748929
[TBL] [Abstract][Full Text] [Related]
15. Midterm follow-up after computed tomography angiography planned left atrial appendage closure.
Rana MA; Yoon S; Dallan LAP; Tashtish N; Attizzani GF; Rashid I; Rajagopalan S; Arruda M; Filby SJ
Catheter Cardiovasc Interv; 2024 Jan; 103(1):129-136. PubMed ID: 37786977
[TBL] [Abstract][Full Text] [Related]
16. Cryoballoon pulmonary vein ablation and left atrial appendage closure combined procedure: A long-term follow-up analysis.
Fassini G; Gasperetti A; Italiano G; Riva S; Moltrasio M; Dello Russo A; Casella M; Maltagliati A; Tundo F; Majocchi B; Arioli L; Al-Mohani G; Pontone G; Pepi M; Tondo C
Heart Rhythm; 2019 Sep; 16(9):1320-1326. PubMed ID: 30928784
[TBL] [Abstract][Full Text] [Related]
17. Left Atrial Appendage Closure in Patients With Atrial Fibrillation at Very High Bleeding Risk Without Postimplantation Antithrombotic Therapy.
Darmon A; Couture EL; Stein G; Cormier B; Chevalier B; Lefèvre T; Sanguineti A; Horvilleur J; Garot P
J Invasive Cardiol; 2020 Oct; 32(10):385-391. PubMed ID: 32999093
[TBL] [Abstract][Full Text] [Related]
18. Stand-Alone Thoracoscopic Left Atrial Appendage Closure in Nonvalvular Atrial Fibrillation Patients at High Bleeding Risk.
Franciulli M; De Martino G; Librera M; Desoky A; Mariniello A; Iavazzo A; Scigliano F; Esposito G; Chiariello L
Innovations (Phila); 2020; 15(6):541-546. PubMed ID: 33048625
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
20. Residual stroke risk after left atrial appendage closure in patients with prior oral anticoagulation failure.
Pracoń R; Zieliński K; Bangalore S; Konka M; Kruk M; Kępka C; Trochimiuk P; Dębski M; Przyłuski J; Kaczmarska E; Dzielińska Z; Kurowski A; Witkowski A; Demkow M
Int J Cardiol; 2022 May; 354():17-21. PubMed ID: 35219744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
